CompoAtlas

EPHYMIND+ gel

Food supplement declared in France, decision dated 6 February 2026

EPHYMIND+ gel is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 point in its composition requires a check (prohibited substance, dose or novel food).

Brand
not provided
Food business operator placing the product on the market
EPHYLA SAS
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Bâton / batônnet / stick
Daily dose
1 stick de 7,5 ml
Directions for use
1 stick, soit 7,5 ml par jour
Intended populations
Hommes et femmes de 18 ans et plus
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Sous antidiabétiques
Objectives stated by the manufacturer (these are not authorised claims)
Concentration

Declaration 355201, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Cannabis sativa L.GrainePoudre (de plantes séchées ou broyées)583.6 mg
Panax ginseng C.A.Mey.RacineExtrait fluide aqueux124.9 mg

Additives

E412, E415, E422, E331, E420

Other ingredients

eau

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line